Not recruiting
Retinitis pigmentosa
Not recruitingLong-Term Safety and Efficacy Study of Botaretigene Sparoparvovec for Patients with X-Linked Retinitis Pigmentosa
Registered drugNo placebo
Long-Term Safety and Efficacy Study of Botaretigene Sparoparvovec for Patients with X-Linked Retinitis Pigmentosa
Registered drugNo placebo
- Disease:Retinitis pigmentosa
- Substances:Cefazolin SodiumCefuroxime+5
Countries:
Belgium
Belgium- Participants:0–17 years · 18–64 years
- Substances:Cefazolin Sodium
- Sponsor:Meiragtx Ocular UK Limited




